Therapeutic Area market research reports by DelveInsight

• Skin Neoplasms - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Skin Neoplasms - Pipeline Insight, 2024 Skin Neoplasms Overview ""Skin Neoplasms Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Skin Neoplasms market. A detailed picture of the Skin Neoplasms pip ... Read More

• CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Multiple Myeloma pipeline landscape. It cover ... Read More

• Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024 DelveInsight’s, “Ventilator Associated Pneumonia - Pipeline Insight, 2024,” report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in Ventilator Associated Pneumonia pipeline landscape. It covers the pipeline d ... Read More

• Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024 DelveInsight’s, “Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Post-traumatic Stress Disorder (PTSD) pipeline landscape. It covers th ... Read More

• Anorexia Nervosa - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anorexia Nervosa - Pipeline Insight, 2024 DelveInsight’s, “Anorexia Nervosa - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anorexia Nervosa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More

• Advanced Renal Cell Carcinoma- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More

• H3N2 infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  H3N2 infection - Pipeline Insight, 2024 DelveInsight’s, “H3N2 infection- Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in H3N2 infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• HER2 Negative Breast Cancer- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More

• Unresectable Melanoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Unresectable Melanoma - Pipeline Insight, 2024 Unresectable Melanoma Overview ""Unresectable Melanoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Unresectable Melanoma market. A detailed pictu ... Read More

• Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uncomplicated Urinary Tract Infections - Pipeline Insight, 2024 Uncomplicated Urinary Tract Infections Overview ""Uncomplicated Urinary Tract Infections Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

• Actinic Keratosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Actinic Keratosis - Pipeline Insight, 2024 Actinic Keratosis Overview ""Actinic Keratosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Actinic Keratosis market. A detailed picture of the Actini ... Read More

• Acute Coronary Syndrome - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Coronary Syndrome - Pipeline Insight, 2024 Acute Coronary Syndrome Overview ""Acute Coronary Syndrome Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Coronary Syndrome market. A detail ... Read More

• Acute Decompensated Heart Failure (ADHF) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Decompensated Heart Failure (ADHF) - Pipeline Insight, 2024 Acute Decompensated Heart Failure (ADHF) Overview ""Acute Decompensated Heart Failure (ADHF) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects ... Read More

• Acute Kidney Injury (AKI) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Kidney Injury (AKI) - Pipeline Insight, 2024 Acute Kidney Injury (AKI) Overview ""Acute Kidney Injury (AKI) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Kidney Injury (AKI) market. ... Read More

• Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 Acute Lymphoblastic Leukemia (ALL) Overview ""Acute Lymphoblastic Leukemia (ALL) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute L ... Read More

• Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2024 Acute Renal Failure (ARF) (Acute Kidney Injury) Overview ""Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario ... Read More

• Complicated Urinary Tract Infections - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Complicated Urinary Tract Infections - Pipeline Insight, 2024 DelveInsight’s, “Complicated Urinary Tract Infections – Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Complicated Urinary Tract Infections pipeline landscape. It covers the p ... Read More

• Equine encephalitis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Equine encephalitis - Pipeline Insight, 2024 DelveInsight’s, “Equine encephalitis - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Equine encephalitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclin ... Read More

• Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024 DelveInsight’s, “Cognitive Impairment Associated with Schizophrenia-CIAS- Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cognitive Impairment Associated with Sc ... Read More

• Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024 Autoimmune pulmonary alveolar proteinosis (aPAP) Overview ""Autoimmune pulmonary alveolar proteinosis (aPAP) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenar ... Read More

• Astigmatism - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Astigmatism - Pipeline Insight, 2024 Astigmatism Overview ""Astigmatism Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Astigmatism market. A detailed picture of the Astigmatism pipeline landscape ... Read More

• Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. I ... Read More

• Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline ... Read More

• Visceral Pain associated with GI disorders - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Visceral Pain associated with GI disorders - Pipeline Insight, 2024 Visceral Pain associated with GI disorders Overview ""Visceral Pain associated with GI disorders Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

• Ocular Inflammation and Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Ocular Inflammation and Pain - Pipeline Insight, 2024 DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ocular Inflammation and Pain pipeline landscape. It covers the pipeline drug profiles, inc ... Read More

< prev 13 14 15 16 17 18 19 20 21 22 next >